raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:199351

PLA2G6-related neurodegeneration, adult-onset

Synonyms: Dystonia-parkinsonism, Paisan-Ruiz type · PARK14 · PLA2G6-related dystonia-parkinsonism · PLA2G6-associated neurodegeneration, adult-onset · Adult-onset dystonia-parkinsonism · Adult PLAN · Adult phospholipase A2-associated neurodegeneration

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Adult
Status
active

A rare neurodegenerative disease usually presenting before the age of 30 and which is characterized by dystonia, L-dopa-responsive parkinsonism, pyramidal signs and rapid cognitive decline.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPLA2G6-related neurodegeneration, adult-onsetDystonia-parkinsonism, Paisan-Ruiz type · PARK14 · PLA2G6-related dystonia-parkinsonism · PLA2G6-associated neurodegeneration, adult-onset · Adult-onset dystonia-parkinsonism · Adult PLAN · Adult phospholipase A2-associated neurodegeneration
frNeurodégénérescence de l'adulte associée à PLA2G6Dystonie-parkinsonisme associées à PLA2G6 · Dystonie-parkinsonisme type Paisan-Ruiz · PARK14 · Dystonie-parkinsonisme de l'adulte · Neurodégénérescence de l'adulte associée à la phospholipase A2
dePLA2G6-assoziierte Neurodegeneration, adulte FormAdulte PLAN · Dystonie-Parkinsonismus mit Beginn im Erwachsenenalter · Dystonie-Parkinson-Syndrom Typ Paisan-Ruiz · PARK14 · PLA2G6-abhängiger-Dystonie-Parkinsonismus · Phospholipase A2-assoziierte Neurodegeneration mit Beginn im Erwachsenenalter
esNeurodegeneración asociada al gen PLA2G6 de inicio en el adultoPLAN en el adulto · Neurodegeneración asociada a la fosfolipasa A2 en el adulto · Distonía-parkinsonismo tipo Paisan-Ruiz · PARK14 · Distonía-parkinsonismo de inicio en el adulto · Distonía-parkinsonismo asociados al gen PLA2G6
itNeurodegenerazione correlata a PLA2G6 ad esordio nell'età adultaDistonia-parkinsonismo PLA2G6-correlato · PLAN dell'adulto · Distonia-parkinsonismo a esordio nell'età adulta · PARK14 · Distonia-parkinsonismo, tipo Paisan-Ruiz · Neurodegenerazione associata a PLA2G6 ad esordio nell'età adulta · Neurodegenerazione associata alla fosfolipasi A2 nell'adulto
nlPLA2G6-gerelateerde neurodegeneratie, volwassen aanvangPLA2G6-geassocieerde neurodegeneratie beginnend op volwassen leeftijd · Dystonie-parkinsonisme beginnend op volwassen leeftijd · PLAN bij volwassene · Neurodegeneratie geassocieerd met fosfolipase A2 bij volwassene · Dystonie-parkinsonisme, Paisan-Ruiz-type · PARK14 · PLA2G6-gerelateerde dystonie-parkinsonisme
ptDistonia-parkinsonismo de início no adultoDistonia-parkinsonismo tipo Paisan-Ruiz
plDystonia-parkinsonizm o początku w wieku dorosłymDystonia-parkinsonizm związana z plA2G6 · Dystonia-parkinsonizm, typ Paisana i Ruiza · PARK14
csDystonie a parkinsonismus s nástupem v dospělostiDystonie a parkinsonismus, Paisan-Ruizové typ · PARK14 · Dystonie a parkinsonismus související s PLA2G6
ukДистонія-паркінсонізм у дорослихДистонія-паркінсонізм, тип Пайсан-Руїса · PARK14 · Дистонія-паркінсонізм, повязана з PLA2G6
zh成人发病的肌张力障碍-帕金森综合征Paisan-Ruiz型肌张力障碍-帕金森症
trYetişkin başlangıçlı distoni-parkinsonizmPARK14 · PLA2G6-ilişkili distoni-parkinsonizm · Distoni-parkinsonizm, Paisan-Ruiz tipi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM612953Evalidated
ICD-10G24.1NTBTattributedvalidated
ICD-118A00.1YNTBTindexvalidated
MONDO0013060Evalidated
MeSHC567844Evalidated
UMLSC2751842Evalidated
GARD12568Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PLA2G6Disease-causing germline mutation(s) inAssessedHGNC:9039ENSG0000018438160360422q13.1phospholipase A2 group VI
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families14 casesWorldwideCase(s)Validated18570303[PMID]_20938027[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

32 annotations · validated 2018-04-23
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0040081Abnormal circulating creatine kinase concentration
HP:0002067Bradykinesia
HP:0002312Clumsiness
HP:0001260Dysarthria
HP:0010522Dyslexia
HP:0002015Dysphagia
HP:0000658Eyelid apraxia
HP:0004373Focal dystonia
HP:0006892Frontotemporal cerebral atrophy
HP:0002145Frontotemporal dementia
HP:0007058Generalized cerebral atrophy/hypoplasia
HP:0001347Hyperreflexia
HP:0000571Hypometric saccades
HP:0000338Hypomimic face
HP:0002185Neurofibrillary tangles
HP:0002548Parkinsonism with favorable response to dopaminergic medication
HP:0002172Postural instability
HP:0007153Progressive extrapyramidal movement disorder
HP:0002063Rigidity
HP:0001257Spasticity
HP:0025262Stiff hip
HP:0001337Tremor
Occasional (29-5%)
HP:0000746Delusion
HP:0000716Depression
HP:0001332Dystonia
HP:0001263Global developmental delay
HP:0012675Iron accumulation in brain
HP:0001336Myoclonus
HP:0011999Paranoia
HP:0000751Personality changes
HP:0001250Seizure
HP:0000605Supranuclear gaze palsy

Annotation source: 26196026[PMID]_20619503[PMID]_20938027[PMID]_21700586[PMID]_22030388[PMID]_20482602[PMID]

7

Sources for this card